BFA
VNDA icon

BlackRock Fund Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

BlackRock Fund Advisors’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$36.2M Buy
2,270,297
+679,195
+43% +$10.9M 0.01% 1873
2016
Q3 		$26.5M Buy
1,591,102
+74,095
+5% +$998K 0.01% 1934
2016
Q2 		$17M Sell
1,517,007
-125,063
-8% -$1.21M ﹤0.01% 2116
2016
Q1 		$13.7M Buy
1,642,070
+19,224
+1% +$158K ﹤0.01% 2193
2015
Q4 		$15.1M Sell
1,622,846
-61,938
-4% -$618K ﹤0.01% 2199
2015
Q3 		$19M Buy
1,684,784
+43,073
+3% +$527K ﹤0.01% 2017
2015
Q2 		$20.8M Buy
1,641,711
+156,520
+11% +$1.69M 0.01% 2093
2015
Q1 		$13.8M Sell
1,485,191
-68,098
-4% -$769K ﹤0.01% 2269
2014
Q4 		$22.2M Buy
1,553,289
+323,759
+26% +$3.83M 0.01% 2005
2014
Q3 		$12.8M Sell
1,229,530
-14,813
-1% -$194K ﹤0.01% 2215
2014
Q2 		$20.1M Sell
1,244,343
-91,696
-7% -$1.22M 0.01% 2018
2014
Q1 		$21.7M Buy
1,336,039
+56,958
+4% +$810K 0.01% 1955
2013
Q4 		$15.9M Sell
1,279,081
-21,050
-2% -$211K ﹤0.01% 2113
2013
Q3 		$14.2M Buy
1,300,131
+331,630
+34% +$3.54M ﹤0.01% 2150
2013
Q2 		$7.83M Buy
+968,501
New +$6.52M ﹤0.01% 2413

Other funds holding VNDA

PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock Fund Advisors's VNDA Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Vanda Pharmaceuticals (VNDA) stake by 43% in Q4 2016, buying an estimated $10.9M and bringing the position to 2,270,297 shares worth $36.2M. The position accounts for 0.01% of the portfolio, ranked #1873.

BlackRock Fund Advisors first reported a position in VNDA in Q2 2013 and has held it in 15 quarters since. 141 funds tracked by Wall St. Rank hold VNDA as of Q4 2016.

  • BlackRock Fund Advisors held 2,270,297 shares of Vanda Pharmaceuticals worth $36.2M as of Q4 2016.
  • BlackRock Fund Advisors bought 679,195 Vanda Pharmaceuticals shares in Q4 2016, an estimated $10.9M.
  • Vanda Pharmaceuticals made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1873 holding.
  • BlackRock Fund Advisors first reported a position in Vanda Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • 141 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.